Aroga Biosciences

01/08/2026

✨ New Year, New Website ✨
Our updated Aroga Biosciences website is now live! We’ve refreshed our design and made it easier to explore our regulatory medical writing and submissions support for biotech and pharmaceutical partners.

Take a look: https://www.arogabio.com/

12/23/2025

Sweet traditions at Aroga 🍪🎄 Our annual Holiday Cookie Exchange brought the team together to share treats and celebrate the season.

12/10/2025

Celebrating the season with our partners at Biocom California! The 2025 Holiday Party was a fantastic reminder of the strength of our community and the meaningful work we’re doing together. Here’s to continued collaboration and growth! 🌟❄️

11/18/2025

Aroga was honored to attend the AMWA 2025 Conference, joining leaders and innovators dedicated to advancing excellence in medical writing. Grateful for the insights, connections, and inspiration that will continue to elevate the work we do. Looking forward to driving impactful change together!

11/06/2025

Aroga Biosciences is proud to announce that our team will be presenting at the 2025 AMWA Medical Writing & Communication Conference in Phoenix, AZ!

Aroga is committed to advancing quality and innovation in medical and regulatory writing, and we’re honored to contribute to this year’s AMWA program.

10/30/2025

Aroga Biosciences is proud to be a Gold Sponsor of the 2025 AMWA Conference in Phoenix, AZ!

We look forward to connecting with fellow medical writing and regulatory professionals to share insights and strengthen our partnerships.

10/09/2025

The Aroga team was proud to take part in the CureSearch Walk, joining the fight to end childhood cancer. 💜

Together, we raised funds to support lifesaving research for children and families facing this battle. Every step brings hope—and brings us closer to a cure.

09/25/2025

This September, Aroga Biosciences is proud to honor Childhood Cancer Awareness Month by supporting CureSearch in the fight against children’s cancer. 💛

👉 Join us in supporting this important cause: https://ow.ly/toi250X2qp4

09/18/2025

✨ What an incredible experience at the San Diego Business Journal’s Best Places to Work 2025 Awards!

We’re proud and honored that Aroga Biosciences has been recognized as one of the top places to work this year. It was a joy to celebrate alongside so many inspiring companies—and even more meaningful to share this moment with such an amazing team.🙌

09/11/2025

🏆 We’re honored to share that Aroga Biosciences has been named a 𝗕𝗲𝘀𝘁 𝗣𝗹𝗮𝗰𝗲 𝘁𝗼 𝗪𝗼𝗿𝗸 𝟮𝟬𝟮𝟱 by the San Diego Business Journal!

This recognition, in partnership with Workforce Research Group, highlights companies that cultivate workplaces where employees feel proud to belong. At Aroga, we’re dedicated to building a culture rooted in purpose, growth, and excellence—every single day.

Read more here: https://www.sdbj.com/

09/04/2025

We’re honored to be recognized by the San Diego Business Journal as one of the Top 2025 Biotech & Biopharma Companies! 🎉

A huge thank you to our dedicated team and valued partners who make this possible.

Read more at: http://sdbj.com/

08/26/2025

✨ Your Expertise Needed on Interpretation of ICH M4S(R2) for Nonclinical Regulatory Submissions ✨
(10 min + $50 gift card raffle)

Greetings!
We’re looking for the opinion of experts on preparing nonclinical content for regulatory drug submissions.

By filling out this survey, you will contribute to advancing awareness of variability in reporting nonclinical data — and you can enter for a chance to win a $50 Amazon gift card! 🎁

📋 Survey Overview

⏱️ Time: 5–10 minutes

❓ Questions: 11 multiple choice + 1 open-feedback response

👩‍🔬 Eligibility: Experience preparing nonclinical content for drug applications in the past 5 years

🔒 Privacy: Confidential. Email submission is optional and used only for raffle entry

📅 Deadline: September 30, 2025

👉 TAKE SURVEY: https://ow.ly/PM8L50WMs5G

🙌 Thank you for your participation!

We’re conducting a short survey to understand how International Conference on Harmonisation (ICH) M4S(R2) guidance is interpreted and applied for reporting nonclinical data in regulatory submissions for drug development and approval. Your input will help identify and increase awareness of variabil...